Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
CTKB — Cytek Biosciences, Inc.
NASDAQ
FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 5, 2025
REVENUE
$52.3M +14.7%
NET MARGIN
-10.5% +1.8 PTS
EPS
-$0.04 +2.5%
FREE CASH FLOW
-$4.6M -209.9%

No summary has been written for this call yet.